Brief: China Regenerative Medicine International Qtrly Loss Attributable HK$134.9 Million
10/08/2018 14:02
Aug 10 (Reuters) - China Regenerative Medicine International
Ltd 8158.HK :
* QTRLY LOSS ATTRIBUTABLE HK$134.9 MILLION VERSUS LOSS OS
HK$35.3
MILLION
* QTRLY REVENUE HK$40.1 MILLION VERSUS HK$75.6 MILLION
Source text for Eikon: ID:nHKS31Wclz
Further company coverage: 8158.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on China Regenerative Medicine International
See all newsBrief: China Regenerative Medicine International Expects FY Profit To Increase At Least 28%
Brief: China Regenerative Medicine International Says Yan Shibin Will Be Appointed As CFO
Brief: China Regenerative Medicine International Posts H1 Revenue Of HKD59.78 Mln
Brief: China Regenerative Medicine International Posts FY Loss Attributable HK$107.7 Mln
Brief: China Regenerative Medicine International Says Subscription Of Increased Registered Capital